CHELMSFORD, Mass.--(BUSINESS WIRE)-- ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that ZOLL defibrillators are ranked ...

A half-dozen security vulnerabilities recently identified in older versions of the Zoll Defibrillator Dashboard could allow a remote attacker to take control of the device management platform, ...

ZOLL AED 3 continues ZOLL's tradition of providing best-in-class AEDs to help improve outcomes from sudden cardiac arrest (SCA) by removing the guesswork for bystanders and giving them the confidence ...

CHELMSFORD, Mass., September 30, 2025--(BUSINESS WIRE)--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most ...

Zoll Medical Corp. of Chelmsford announced today it has received 510(k) clearance from the U.S. Food and Drug Administration to market and begin distributing a new monitor/defibrillator in the United ...

CHELMSFORD — Zoll Medical Corp. is the first medical-device manufacturer to receive pre-market approval from the U.S. Food and Drug Administration to continue to market and distribute its entire line ...

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL ® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, today announced that its ZOLL AED 3 ® and ZOLL ...

The ZOLL® AED Plus® continues to set the benchmark for design, dependability, durability, and performance. Only half of sudden cardiac arrest victims will initially need a shock, but all require ...

Automated external defibrillator (AED) developer Zoll announced today that it appointed Eric Knudsen as its new CEO.

On August 3, 2017, a Boston jury awarded Philips $10.4 million in damages for ZOLL’s infringement of three patents relating to automated external defibrillators. This represents only a fraction of the ...